Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy.
Moyenuddin
Munshi
M
Ohl
Christopher A
CA
Williamson
John C
JC
Peacock
James E
JE
D000368:Aged; D004359:Drug Therapy, Combination / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010068:Oxacillin / Q000494:pharmacology / Q000627:therapeutic use*; D010403:Penicillin Resistance / Q000502:physiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use*; D014769:Virginiamycin / Q000494:pharmacology / Q000627:therapeutic use*
D014769:Virginiamycin; C062940:quinupristin-dalfopristin; D014640:Vancomycin; D010068:Oxacillin